Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 8Breast Neoplasms 7Carcinoma, Non-Small-Cell Lung 6Pancreatic Neoplasms 4Nasopharyngeal Carcinoma 3Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Neoplasms 2Neoplasm Metastasis 2Meningioma 2Liver Neoplasms 2HER2-positive Breast Cancer 2Glioma 2Glioblastoma 2Chordoma 2Carcinoma, Hepatocellular 2Carcinoma, Adenoid Cystic 2Brain Neoplasms 2Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Small Cell Lung Carcinoma 1Sinonasal undifferentiated carcinoma 1Resectable Lung Non-Small Cell Carcinoma 1Radiation Injuries 1Pituitary Neoplasms 1Oligodendroglioma 1Neurilemmoma 1Nerve Sheath Neoplasms 1

Interventions

pembrolizumab 160Carboplatin 143Paclitaxel 125Cyclophosphamide 93130-nm albumin-bound paclitaxel 66Capecitabine 63Gemcitabine 54Doxorubicin 49Albumin-Bound Paclitaxel 45Taxes 42atezolizumab 40Cisplatin 37Nivolumab 34sacituzumab govitecan 32olaparib 32Epirubicin 32Docetaxel 28eribulin 27Specimen Handling 26Bevacizumab 26durvalumab 25camrelizumab 23Drug Therapy 22Biopsy 22Magnetic Resonance Spectroscopy 21toripalimab 18Radiotherapy 17spartalizumab 16Everolimus 15fludarabine 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Triple Negative Breast Neoplasms × Protons × Clear all
NCT05692661 2023-01-20

A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer

Shanghai Proton and Heavy Ion Center

Phase 1 Unknown
24 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡